Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators
1996 ◽
Vol 7
(5)
◽
pp. 548-557
◽
2016 ◽
Vol 3
(2)
◽
pp. 138-146
◽
2009 ◽
Vol 65
(4)
◽
pp. 719-726
◽
2014 ◽
Vol 14
(4)
◽
pp. 528-538
Keyword(s):